Plasma Proteome Analysis of Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Establishes Neurofilament Light Chain (NfL) as a Biomarker of Disease and Treatment Response
Simina Ticau, Gautham V Sridharan, Shira Tsour, William L Cantley, Amy Chan, Jason A Gilbert, David Erbe, Mary M Reilly, David Adams, Michael Polydefkis, Kevin Fitzgerald, Akshay Vaishnaw, Paul Nioi
doi: https://doi.org/10.1101/19011155
Simina Ticau
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Gautham V Sridharan
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Shira Tsour
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
William L Cantley
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Amy Chan
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Jason A Gilbert
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
David Erbe
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Mary M Reilly
2MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom
David Adams
3AP-HP. Université Paris-Saclay, CHU Bicêtre, INSERM U1195, Le Kremlin Bicêtre, France
Michael Polydefkis
4Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Kevin Fitzgerald
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Akshay Vaishnaw
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Paul Nioi
1Alnylam Pharmaceuticals, 300 Third Street Cambridge, MA
Data Availability
Not applicable
Posted November 08, 2019.
Plasma Proteome Analysis of Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Establishes Neurofilament Light Chain (NfL) as a Biomarker of Disease and Treatment Response
Simina Ticau, Gautham V Sridharan, Shira Tsour, William L Cantley, Amy Chan, Jason A Gilbert, David Erbe, Mary M Reilly, David Adams, Michael Polydefkis, Kevin Fitzgerald, Akshay Vaishnaw, Paul Nioi
medRxiv 19011155; doi: https://doi.org/10.1101/19011155
Plasma Proteome Analysis of Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Establishes Neurofilament Light Chain (NfL) as a Biomarker of Disease and Treatment Response
Simina Ticau, Gautham V Sridharan, Shira Tsour, William L Cantley, Amy Chan, Jason A Gilbert, David Erbe, Mary M Reilly, David Adams, Michael Polydefkis, Kevin Fitzgerald, Akshay Vaishnaw, Paul Nioi
medRxiv 19011155; doi: https://doi.org/10.1101/19011155
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (448)
- Epidemiology (12891)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4686)
- Geriatric Medicine (431)
- Health Economics (738)
- Health Informatics (2981)
- Health Policy (1081)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (437)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4475)
- Nursing (239)
- Nutrition (656)
- Oncology (2323)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1213)
- Primary Care Research (509)
- Public and Global Health (7061)
- Radiology and Imaging (1570)
- Respiratory Medicine (930)
- Rheumatology (450)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)